ask="0.73"
ask_size="2900"
average_daily_volume="12492"
bid="0.69"
bid_size="500"
book_value="0.28"
change="+0.11"
change_from_200_day_moving_average="-0.21"
change_from_50_day_moving_average="0.04"
change_from_52_week_high="-0.86"
change_From_52_week_low="0.22"
change_in_percent="+17.74%"
close="0.73"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="8736000"
high="0.78"
high_52_weeks="1.59"
last_trade_date="1/12/2017"
last_trade_price="0.73"
last_trade_size="300"
last_trade_time="4:00pm"
low="0.59"
low_52_weeks="0.51"
market_capitalization="9.78M"
moving_average_200_day="0.94"
moving_average_50_day="0.69"
name="XTL Biopharmaceuticals Ltd. - A"
notes="N/A"
one_year_target_price="6.00"
open="0.59"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-21.98%"
percent_change_from_50_day_moving_average="+6.36%"
percent_change_from_52_week_high="-54.09%"
percent_change_from_52_week_low="+43.14%"
previous_close="0.62"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.21"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="13400000"
short_ratio="0.40"
stock_exchange="NCM"
symbol="XTLB"
volume="228459"
weeks_range_52="0.51 - 1.59"
